Correlation Engine 2.0
Clear Search sequence regions


In this review, we present the evidence on the safety and efficacy of anticholinergic therapy for men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and emphasize the data published over the past year. This review discusses two classes of medications whose mechanism of action attenuates the effect of acetylcholine on the LUT: anticholinergics and botulinum toxin. We review the randomized controlled trials that investigate the efficacy and side effects of anticholinergics when used in men with LUTS secondary to BPH. We emphasize new studies and developments that have been made in the past year.

Citation

Steven J Weissbart, Bilal Chughtai, Dean Elterman, Richard Lee, Alexis Te, Steven Kaplan. Acetylcholine for male LUTS. Current urology reports. 2012 Dec;13(6):413-9

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22923069

View Full Text